Stuart R. Levine

Stuart R. Levine discloses dealings in 2 companies, chiefly Broadridge Financial Solutions, Inc. and Gentiva Health Services Inc. In total, 68 filings cover trades dated from 2 December 2008 to 3 October 2019.

Both buying and selling appear: 5 purchases worth €108k, against 6 sales worth €9.3M. Sales outweigh purchases by €9.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 43 share grants and 14 option exercises. Since January 2019: no purchases and 2 sales on the market.

In size, the median ticket on the buying side is €20k.

The latest filing, published on 7 October 2019, reports a share grant in Broadridge Financial Solutions, Inc. The most recent open-market purchase was published on 9 February 2010, 6,116 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.